Brief: TScan Therapeutics Presents Preclinical Data For Solid Tumor Program
11/11/2022 12:16
Nov 11 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS PRESENTS PRECLINICAL DATA FOR SOLID
TUMOR
PROGRAM AT THE 37TH SOCIETY FOR IMMUNOTHERAPY OF CANCER ANNUAL
MEETING
Source text for Eikon: ID:nGNX8BPJfT
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing